salvage autologous hematopoietic cell transplantation
Showing 26 - 50 of >10,000
Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Venetoclax
- +5 more
- (no location specified)
May 9, 2023
Chemo-induced Nausea and Vomiting Trial in Istanbul (Breathing exercise group, Control group)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- Breathing exercise group
- Control group
-
Istanbul, TurkeyKoç University Hospital
Apr 6, 2022
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Lymphoma Trial in Hangzhou (Autologous hematopoietic stem cell transplantation combined with CD19 CAR-T cells)
Recruiting
- Lymphoma
- Autologous hematopoietic stem cell transplantation combined with CD19 CAR-T cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Feb 13, 2022
Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)
Completed
- Multiple Myeloma
-
Stanford, CaliforniaStanford University
Aug 17, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in La Jolla (Autologous hematopoietic stem cell transplantation,
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Autologous hematopoietic stem cell transplantation
- +2 more
-
La Jolla, CaliforniaScripps Green Hospital
Aug 16, 2022
Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cells
- +8 more
-
Freiburg, Baden-Württemberg, Germany
- +31 more
Jan 5, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)
Completed
- Multiple Myeloma
- Uproleselan
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)
Recruiting
- Hematopoietic Organs; Disorder
- CD62L depleted donor lymphocyte infusion
-
Hong Kong, Hong KongHong Kong Children's Hospital
Sep 6, 2023
Factors Impeding Physical Activity During Post-discharge Period
Not yet recruiting
- Physical Activities
- interview
- (no location specified)
Oct 24, 2023
Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)
Not yet recruiting
- Acute Graft Versus Host Disease
- Hematopoietic and Lymphoid System Neoplasm
- Fecal Microbiota Transplantation Capsule
- Placebo
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2023
Hematopoietic Tumors, Hematopoietic Malignancy Trial in Boston (STEPP Intervention, Usual Care)
Not yet recruiting
- Hematopoietic Neoplasms
- Hematopoietic Malignancy
- STEPP Intervention
- Usual Care
-
Boston, Massachusetts
- +1 more
Aug 30, 2023
Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)
Recruiting
- Lymphoma
- +4 more
- Pharmacokinetics
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 12, 2022
Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)
Not yet recruiting
- Recurrent Classic Hodgkin Lymphoma
- Refractory Classic Hodgkin Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- +13 more
- (no location specified)
Feb 2, 2023
Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,
Terminated
- Relapsing-Remitting Multiple Sclerosis
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Hamburg, Germany
- +1 more
Mar 1, 2022
Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)
Not yet recruiting
- Thrombotic Disorder
- N-acetyl-cysteine
- +3 more
- (no location specified)
Jun 8, 2023
Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)
Recruiting
- Hematopoietic Organs; Disorder
- Total lymphoid irradiation
-
Hong Kong, Hong KongHong Kong Children's Hospital
Oct 4, 2023
Blood Virome After Haploidentical Hematopoietic Stem Cell
Recruiting
- Haploidentical Hematopoietic Stem Cell Transplantation
-
Geneva, SwitzerlandGeneva University Hospitals
Nov 21, 2022
Liver Transplantation, Erythrocyte Transfusion Trial in Rome (Red Blood Cell concentrates from organ donor)
Not yet recruiting
- Liver Transplantation
- Erythrocyte Transfusion
- Red Blood Cell concentrates from organ donor
-
Rome, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023
Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)
Recruiting
- Acute Lymphoblastic Leukemia
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Nov 5, 2023
Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)
Completed
- Acute,Leukemia, Lymphoid
- Dasatinib
- +12 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Aug 2, 2022
Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood
Recruiting
- Hematopoietic Malignancy
- +2 more
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Nov 6, 2023
Infectious and Noninfectious Lung Diseases Following Allogeneic
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023